TerminatedNCT00715377

Anticholinergic Burden in Schizophrenia

Medication studyAges 50+Canada

The study in practice

Understand this study

This study is for people with schizophrenia. Listed age limits: from 50 years. Other eligibility criteria apply.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateJune 2007

Recruitment status: Terminated
Enrollment listed in the registry: 2
Sponsor: Centre for Addiction and Mental Health
Sponsor type: Hospital / academic medical center
Study type: Drug
Intervention type: Medication / drug
Study phase: Not clearly listed
Locations: Canada
Age range: Over 50 Years
Official registry ID: NCT00715377
Official title: Show the full official title
Anticholinergic Burden in Schizophrenia

Terminated

Toronto

FAQ

Who is behind this study?

The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including Benztropine.

Who can participate?

This study is for people with schizophrenia. Listed age limits: from 50 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.